An efficient, sustainable, and regioselective one-pot synthesis of hitherto unreported 4-aroyl/hetaroyl/alkanoyl-5-alkyl/allyl/benzylsulfanyl-1,2,3-thiadiazoles has been achieved by [3 + 2] cycloaddition of α-enolicdithioesters with tosyl azide through cascade 1â2 (SâN) and 3â4 (CâN) bond connections involving Wolff-type heterocyclization. Optimally, the reactions are very fast and completed within 2â15 minutes, when a mixture of α-enolicdithioester and tosyl azide was stirred at 0 °C in the presence of Et3N under solvent-free conditions. Furthermore, no co-catalyst or activator is necessary. The eco-compatibility, mild conditions, excellent yields, easy purification, and avoidance of expensive/toxic reagents are advantages of this protocol to access this medicinally privileged substructure.
通过 α 的 [3 + 2] 环加成,实现了迄今为止未报道的 4-芳酰基/杂酰基/烷酰基-5-烷基/烯丙基/苄基
硫基-1,2,3-
噻二唑的高效、可持续和区域选择性一锅法合成-烯醇二
硫酯与
甲苯磺酰
叠氮通过级联 1–2 (S–N) 和 3–4 (C–N) 键连接,涉及 Wolff 型杂环化。最理想的是,当α-烯醇二
硫酯和
甲苯磺酰
叠氮化物的混合物在无溶剂条件下、Et3N存在下于0℃搅拌时,反应非常快并在2-15分钟内完成。此外,不需要助催化剂或活化剂。生态相容性、温和的条件、优异的产量、易于纯化和避免昂贵/有毒试剂是该协议获得这种医学上特权子结构的优点。